These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 30449859

  • 41. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
    Sonnenblick A, Meirovitz A.
    Int J Clin Oncol; 2010 Aug; 15(4):420-2. PubMed ID: 20217448
    [Abstract] [Full Text] [Related]

  • 42. [A Case of Phrenic Nerve Paralysis During Adjuvant Chemotherapy for Rectal Cancer].
    Yabe N, Tamura E, Kitahama K, Ozawa H, Tajima Y, Takenoya T, Oto I, Yoshikawa T, Kojima K, Murai S, Hasegawa H, Kitagawa Y.
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1916-1918. PubMed ID: 29394819
    [Abstract] [Full Text] [Related]

  • 43. Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.
    Minami K, Morita M, Emi Y, Okamoto M, Tanaka E, Nagata S, Touyama T, Ohgaki K, Tanaka T, Okumura H, Suenaga T, Tokunaga S, Oki E, Kakeji Y, Akagi Y, Baba H, Natsugoe S, Maehara Y, Kyushu Study Group of Clinical Cancer (KSCC).
    Int J Clin Oncol; 2017 Jun; 22(3):505-510. PubMed ID: 28101757
    [Abstract] [Full Text] [Related]

  • 44. Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients.
    van Erning FN, Razenberg LG, Lemmens VE, Creemers GJ, Pruijt JF, Maas HA, Janssen-Heijnen ML.
    Eur J Cancer; 2016 Jul; 61():1-10. PubMed ID: 27128782
    [Abstract] [Full Text] [Related]

  • 45. Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-fluorouracil-based chemotherapy.
    Wettergren Y, Carlsson G, Odin E, Gustavsson B.
    Cancer; 2012 Jun 01; 118(11):2935-43. PubMed ID: 22020693
    [Abstract] [Full Text] [Related]

  • 46. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
    Murayama M, Kohno T, Miyazawa M, Shimazaki A, Miyaki A, Usuda A, Asaka S, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.
    Gan To Kagaku Ryoho; 2013 Nov 01; 40(12):2014-6. PubMed ID: 24393997
    [Abstract] [Full Text] [Related]

  • 47. [Severe Therapy-Related Pancytopenia Caused by UFT and LV in a Patient with Ascending Colon Cancer].
    Akiyama T, Yasutomi J, Kusashio K, Matsumoto M, Suzuki T, Iida A, Imamura N, Yoshizumi A, Harano R, Udagawa I, Ohtsuka M.
    Gan To Kagaku Ryoho; 2017 Nov 01; 44(12):1399-1401. PubMed ID: 29394647
    [Abstract] [Full Text] [Related]

  • 48. Severe rhabdomyolysis related to oxaliplatin adjuvant therapy for colorectal cancer.
    Pissarra A, Malheiro M, Matos LV, Plácido AN.
    BMJ Case Rep; 2019 Apr 16; 12(4):. PubMed ID: 30996068
    [Abstract] [Full Text] [Related]

  • 49. Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
    Formica V, Zaniboni A, Loupakis F, Roselli M.
    Int J Cancer; 2018 Nov 15; 143(10):2342-2350. PubMed ID: 29873066
    [Abstract] [Full Text] [Related]

  • 50. [A Case of Two Curative Resections for the Peritoneal Dissemination of Transverse Colon Cancer].
    Kato S, Miyake M, Uemura M, Kato T, Fujiwara A, Maeda S, Hamakawa T, Hama N, Nishikawa K, Miyazaki M, Miyamoto A, Hirao M, Takami K, Sekimoto M.
    Gan To Kagaku Ryoho; 2019 Dec 15; 46(13):2479-2481. PubMed ID: 32156971
    [Abstract] [Full Text] [Related]

  • 51. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.
    Lerdkiattikorn P, Chaikledkaew U, Lausoontornsiri W, Chindavijak S, Khuhaprema T, Tantai N, Teerawattananon Y.
    Expert Rev Pharmacoecon Outcomes Res; 2015 Dec 15; 15(4):687-700. PubMed ID: 25327502
    [Abstract] [Full Text] [Related]

  • 52. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
    Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J, Price T, Lim R, Van Cutsem E, Park YS, McKendrick J, Topham C, Soler-Gonzalez G, de Braud F, Hill M, Sirzén F, Haller DG.
    J Clin Oncol; 2007 Jan 01; 25(1):102-9. PubMed ID: 17194911
    [Abstract] [Full Text] [Related]

  • 53. [Progression of adjuvant chemotherapy for colon cancer].
    He YJ, Dong QM, Li YH.
    Ai Zheng; 2005 Dec 01; 24(12):1546-9. PubMed ID: 16351811
    [Abstract] [Full Text] [Related]

  • 54. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD, Lee SI, Moon HY.
    Hepatogastroenterology; 2012 Dec 01; 59(113):104-7. PubMed ID: 22251527
    [Abstract] [Full Text] [Related]

  • 55. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
    Lu CS, Chang PY, Chen YG, Chen JH, Wu YY, Ho CL.
    PLoS One; 2015 Dec 01; 10(9):e0138632. PubMed ID: 26382962
    [Abstract] [Full Text] [Related]

  • 56. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A, Casadaban L, Maker AV.
    J Surg Res; 2017 Jul 01; 215():12-20. PubMed ID: 28688636
    [Abstract] [Full Text] [Related]

  • 57. Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study).
    Kosugi C, Koda K, Ishibashi K, Yoshimatsu K, Tanaka S, Kato R, Kato H, Oya M, Narushima K, Mori M, Shuto K, Ishida H.
    Int J Colorectal Dis; 2018 Jun 01; 33(6):809-817. PubMed ID: 29484450
    [Abstract] [Full Text] [Related]

  • 58. [A Case of Severe Aortic Thrombosis during the First Chemotherapy Regimen of CapeOX plus Bevacizumab for Metastatic Colon Cancer].
    Korehisa S, Kabashima A, Nambara S, Watanabe K, Umeda K, Koso H, Tahara K, Nakamura Y, Anai H.
    Gan To Kagaku Ryoho; 2020 Jun 01; 47(6):989-992. PubMed ID: 32541181
    [Abstract] [Full Text] [Related]

  • 59. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
    Jonker DJ, Spithoff K, Maroun J, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
    Clin Oncol (R Coll Radiol); 2011 Jun 01; 23(5):314-22. PubMed ID: 21397476
    [Abstract] [Full Text] [Related]

  • 60. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY, Kim YJ, Lee KW, Lee JS, Kim DW, Kang SB, Lee HS, Jang NY, Kim JS, Kim JH.
    Jpn J Clin Oncol; 2013 Feb 01; 43(2):132-8. PubMed ID: 23204187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.